STOCKHOLM - August 28, 2020 - Ola Lindblad, VP Medical Imgaing of ContextVision,
has on August 27, 2020 purchased 1,800 shares in ContextVision AB at an average
price of NOK 22.37 per share. After the transaction, Mr Lindblad holds a total
of 6,300 shares in ContextVision AB.

For further information, please contact ContextVision's CEO, Fredrik Palm, at
+46 76 870 25 43 or visit www.contextvision.com.

                                      ###

About ContextVision

ContextVision is a medical technology software company specialized in image
analysis and artificial intelligence. As the global market leader within image
enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-
ray and MRI equipment around the world.

Our expertise is to develop powerful software products, based on proprietary
technology and artificial intelligence for image-based applications. Our
cutting-edge technology helps clinicians accurately interpret medical images, a
crucial foundation for better diagnosis and treatment.

ContextVision is now entering the fast-growing digital pathology market. We are
re-investing significantly in our product portfolio of decision support tools
and we are dedicated to becoming a leading resource for pathologists to
radically develop cancer diagnosis and improve patient care.

The company, established in 1983, is based in Sweden with local representation
in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock
Exchange under the ticker COV.

This information is subject to the disclosure requirements pursuant to section
5 -12 of the Norwegian Securities Trading Act